Sector expertise
We specialize in four sectors that are poised for robust and sustainable growth – Health & Wellness, the Food Value Chain, Technology, and Business Services – where our private equity expertise gives us a valuable competitive advantage. Ardian provides our portfolio companies with a strategic partner that offers in-depth market experience and an extensive network within the sector.
-
100+
investments and over 320 build-ups since 1997
Health & Wellness
The sector benefits from long-term, secular growth trends such as: an aging population, rapid technological advancements, an increased focus on well-being, and the spread of chronic diseases. Our team invests across the value chain, from drug development to care delivery, identifying opportunities that improve patient outcomes at every stage.
-
€3.8bn
invested since inception, 20 transactions
-
BuyoutBiofarma Group
Italy
Healthcare & life scienceHealthcare & life scienceBiofarma is the global leading player in the development, manufacturing, and packaging of health supplements, medical devices and cosmetics for large Pharma and CPG clients.
Biofarma offers its clients an integrated offer, from market intelligence, R&D and regulatory support, to manufacturing and packaging of finished dosage form products. Biofarma differentiates itself for its capacity to develop and proactively offer its clients innovative solutions by combining differentiated manufacturing technologies, delivery systems, and formulation capabilities. In addition, Biofarma has a strong expertise in probiotics and has an innovative portfolio of Medical Devices, supported by clinical studies and for which it owns dossiers.
As a result of this differentiated positioning, Biofarma is the partner-of-choice of large Pharma and Consumer Health (‘CHCs’) clients for co-development projects requiring strong innovation capabilities, international regulatory capabilities, and manufacturing quality reliability.Deal team
Press releases
